<DOC>
	<DOCNO>NCT00224523</DOCNO>
	<brief_summary>Long term safety ( 52 week ) GW685698X nasal mucosa via nasal biopsy active control group ( Nasonex® ) healthy volunteer control group subject 18 year old perennial allergic rhinitis . Allergic rhinitis inflammatory disorder upper airway occur follow allergen exposure . Perennial allergic rhinitis trigger house dust mite , animal dander , etc. , possibly cause symptom year-round include nasal congestion , rhinorrhea and/or nasal itching .</brief_summary>
	<brief_title>Long Term Safety Of GW685698X Via Nasal Biopsy</brief_title>
	<detailed_description>A Randomized , Open Label , Active Controlled ( Mometasone Furoate Aqueous Nasal Spray [ Nasonex® ] 200mcg QD ) , Parallel Group , Multi-Center , 52-Week Study Assess Long Term Safety GW685698X Aqueous Nasal Spray 100mcg QD via Nasal Biopsy Subjects &gt; 18 Years Age Perennial Allergic Rhinitis ( PAR )</detailed_description>
	<mesh_term>Rhinitis</mesh_term>
	<mesh_term>Rhinitis , Allergic , Perennial</mesh_term>
	<mesh_term>Rhinitis , Allergic</mesh_term>
	<mesh_term>Mometasone Furoate</mesh_term>
	<criteria>Inclusion criterion : History perennial allergic rhinitis 2 year , document positive allergen test appropriate allergen . Female patient childbearing potential must willing consistently correctly use acceptable method birth control . Exclusion criterion : Patients require certain medication allergy . Patients serious medical problem .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2016</verification_date>
	<keyword>perennial allergic rhinitis</keyword>
	<keyword>nasal biopsy</keyword>
	<keyword>GW685698X</keyword>
</DOC>